Skip to main content

Advertisement

Log in

EGR3 regulates opioid-related nociception and motivation in male rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Chronic pain can be a debilitating condition, leading to profound changes in nearly every aspect of life. However, the reliance on opioids such as oxycodone for pain management is thought to initiate dependence and addiction liability. The neurobiological intersection at which opioids relieve pain and possibly transition to addiction is poorly understood. Using RNA sequencing pathway analysis in rats with complete Freund’s adjuvant (CFA)-induced chronic inflammation, we found that the transcriptional signatures in the medial prefrontal cortex (mPFC; a brain region where pain and reward signals integrate) elicited by CFA in combination with oxycodone differed from those elicited by CFA or oxycodone alone. However, the expression of Egr3 was augmented in all animals receiving oxycodone. Furthermore, virus-mediated overexpression of EGR3 in the mPFC increased mechanical pain relief but not the affective aspect of pain in animals receiving oxycodone, whereas pharmacological inhibition of EGR3 via NFAT attenuated mechanical pain relief. Egr3 overexpression also increased the motivation to obtain oxycodone infusions in a progressive ratio test without altering the acquisition or maintenance of oxycodone self-administration. Taken together, these data suggest that EGR3 in the mPFC is at the intersection of nociceptive and addictive-like behaviors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the present study are available from the corresponding author on reasonable request.

References

Download references

Acknowledgements

The NIDA Drug Supply Program generously gifted the oxycodone used in these studies. We thank Karen Dietz for copy editing the manuscript. We also thank Jacob Converse and Mason Hochstetler for their support in conducting experiments.

Funding

This work was supported by the National Institute on Drug Abuse (NIDA; R01DA037257, S1-R01DA037257, and R21DA044486 to D.M.D.), National Institute of Neurological Disorders and Stroke (NINDS; F99NS108543 to J.A.S.), and National Institute of General Medical Sciences (NIGMS; R25GM09545902 to The State University of New York at Buffalo).

Author information

Authors and Affiliations

Authors

Contributions

S.M., S.A.T., J.A.S., J.X.L., and D.M.D. designed experiments. S.M., S.A.T., J.A.S., M.H., J.C., M.I., and K.W. conducted behavioral experiments. J.A.S. and J.W. generated tissues for RNA sequencing. F.J.S. helped with RNA sequencing analysis. M.K.L. and R.C. generated and provided custom viral constructs. S.M. and S.A.T. performed statistical analyses. S.M. wrote the manuscript with review from D.M.D.

Corresponding authors

Correspondence to Swarup Mitra or David M. Dietz.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mitra, S., Thomas, S.A., Martin, J.A. et al. EGR3 regulates opioid-related nociception and motivation in male rats. Psychopharmacology 239, 3539–3550 (2022). https://doi.org/10.1007/s00213-022-06226-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-022-06226-1

Keywords

Navigation